Scientists report encouraging preclinical results of a small molecule called DPM-1001 that robustly reduces copper levels in cells and tissues. It is a potential treatment for Wilson's disease, a serious genetic illness.

Dr. Nick Tonks describes how the serendipity that is inherent to basic research played its part.

More info: [ Ссылка ]

свернуть